| Authors |
Patients (n) |
Discontinuation Rate (%) |
Time From Initiation of Treatment to Survey |
|
| Madduri, 2001 |
55 |
47.3 |
18-21 mo |
| Pryor and Redmon, 2000 |
220 |
46.0 |
NA |
| Fagelman et al, 2001 |
164 |
38.0 |
3-4 mo |
| Fagelman et al, 2001 |
82 |
22.0 |
6-12 mo |
| McMahon et al, 2000 |
304 |
19.5 |
<1 y |
| Madduri, 2001 |
60 |
16.6 |
1-3 mo |
| Giuliano et al, 2000 |
176|| |
14.2¶ |
12 wk |
|
| * In all studies, the sildenafil dose was adjusted as necessary. |
| Renewal information available for 158 patients. |
| 278 men received sildenafil, 186 had prior therapy for ED. |
| Percentage of sildenafil responders who returned to intracavernous
injections. |
| ||Only patients successful with intracavernous injections of 20 µg or
less prostaglandin E1 were included. |
| ¶Percentage of patients who discontinued sildenafil to return to
intracavernous injections. |
|
